BioSpace News Archive

Business

Empower Pharma to Purchase Eugia Manufacturing Facility in New Jersey for Large Scale Expansion of Personalized Compounded Medicine

Empower Clinic Services New Jersey LLC DBA Empower Pharma announced an agreement to purchase a facility in East Windsor, New Jersey from Eugia US Manufacturing LLC and enter into a contract manufacturing relationship.

February 5, 2024

·

3 min read

Biotech Beach

Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today unveiled the G4X™ Spatial Sequencer.

February 5, 2024

·

9 min read

Biotech Beach

Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform

Singular Genomics Systems, Inc. announced groundbreaking new products and capabilities at the Advances of Genome Biology and Technology conference in Orlando, Florida.

February 5, 2024

·

5 min read

BioMidwest

Study Confirms Fears that COVID Pandemic Reduced Kindergarten Readiness

Numerous studies have raised alarms about how the COVID-19 pandemic disrupted learning, development and mental health among school-aged children.

February 5, 2024

·

4 min read

Rapafusyn’s Rick Ewing Acknowledged with Dual Honors for Exceptional Achievements

Baltimore, MD – February 1, 2024 – Rapafusyn proudly announces the distinguished recognition of Dr. Rick Ewing, Vice President of Medicinal Chemistry, for his outstanding contributions to the realms of chemistry and biotechnology innovation.

February 5, 2024

·

2 min read

Biotech Bay

Factorial Biotechnologies Unveils Mosaic™: Enabling Single-Cell Analysis Across All Omic Applications

Factorial Biotechnologies, a leader in next-generation single-cell NGS solutions, unveils Mosaic™, a groundbreaking technology poised to empower researchers to delve deeper into cellular heterogeneity than ever before.

February 5, 2024

·

3 min read

BioCapital

Cartesian Therapeutics Announces New Employment Inducement Grants - February 05, 2024

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, announced the granting of inducement awards to five new employees.

February 5, 2024

·

1 min read

Genetown

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 05, 2024

Astria Therapeutics, Inc., a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 21,000 shares of Astria’s common stock on February 1, 2024 under Astria’s 2022 Inducement Stock Incentive Plan.

February 5, 2024

·

1 min read

Business

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024.

February 5, 2024

·

1 min read

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 05, 2024

Mural Oncology plc announced that on February 2, the Company granted to two newly hired employees non-statutory stock options to purchase an aggregate of 9,425 ordinary shares of the Company and restricted stock units with respect to an aggregate of 5,075 ordinary shares of the Company.

February 5, 2024

·

2 min read